-transparent.png){kind=logo}
The diurnal variation in total and free plasma phenytoin (PHT) concentration at steady state was examined in eight epileptic patients receiving combination therapy with tid valproic acid (VPA) as sodium salt. Eight patients treated with PHT, but not with VPA, were studied for comparison purposes. In the absence of VPA coadministration, total and free PHT concentrations did not change significantly during the day and showed only minor intrapatient fluctuations (14 and 13%, respectively). In patients receiving VPA, the mean total PHT did not change significantly, whereas the free PHT increased during the day (p less than 0.05). The fluctuations in total and free PHT in these patients were 16 and 17% on average. In the presence of VPA, the free PHT fraction was higher than in controls (13.9 +/- 2.3% versus 8.3 +/- 1.9%; p less than 0.01) and fluctuated to a greater extent (29 versus 14% in controls; p less than 0.01), mainly as a result of combined opposite swings in both total and free concentration. The diurnal changes in free PHT concentration and fraction correlated positively with the changes in plasma VPA. An inverse relationship between total PHT concentration and plasma VPA was found in some patients. These data demonstrate that the displacement interaction between PHT and VPA is subject to diurnal variation, probably as a result of the fluctuation in plasma VPA. The implications of these findings are discussed.
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
January 1983,
The Western journal of medicine,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
January 1979,
Therapeutic drug monitoring,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
December 1978,
British journal of clinical pharmacology,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
February 1981,
Epilepsia,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
December 1980,
Clinical pharmacology and therapeutics,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
January 1979,
Therapeutic drug monitoring,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
April 2014,
Journal of pharmacy practice,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
April 1995,
Journal of clinical psychopharmacology,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
January 1993,
Biopharmaceutics & drug disposition,
R Riva, and
F Albani, and
M Contin, and
E Perucca, and
G Ambrosetto, and
G Gobbi, and
M Santucci, and
G Procaccianti, and
A Baruzzi
January 2006,
Anales de pediatria (Barcelona, Spain : 2003),
